Alternative names (1)
studyDesignRandom triples
| Subject | Object |
|---|---|
| gptkb:RE-LY_trial | blinded endpoint evaluation |
| gptkb:NSABP_P-1_trial | gptkb:clinical_trial |
| gptkb:IRS_(Intergroup_Rhabdomyosarcoma_Study) | multi-institutional |
| gptkb:NCT04072952 | Interventional |
| gptkb:CFAS_II | longitudinal |
| gptkb:Worms:_Identifying_Impacts_on_Education_and_Health_in_the_Presence_of_Treatment_Externalities | gptkb:clinical_trial |
| gptkb:PROSPER | gptkb:clinical_trial |
| gptkb:Canakinumab_Anti-inflammatory_Thrombosis_Outcomes_Study | gptkb:clinical_trial |
| gptkb:SURPASS-5 | randomized |
| gptkb:NCT00403767 | Interventional |
| gptkb:SDY-040 | immunology study |
| gptkb:NCT04513366 | Interventional |
| gptkb:CLARITY-AD | randomized |
| gptkb:Women’s_Health_Initiative | observational study |
| gptkb:PREPARE | gptkb:clinical_trial |
| gptkb:NCT04280705 | Interventional |
| gptkb:NCT02475681 | Interventional |
| gptkb:CLARITY-AD | placebo-controlled |
| gptkb:SURPASS-5 | parallel assignment |
| gptkb:Atherosclerosis_Risk_in_Communities_(ARIC)_Study | prospective cohort study |